Evaluation of pharmaceutical quality of phenytoin sodium capsules and tablets from multinational markets

Drug Development and Industrial Pharmacy

Volumn 23, Issue 1, 1997, Pages 47-61

  Farinha, A ^a   Nobrega S D ^a   Paulo, M G ^a  

^a Laboratorio de Estudos Farmaceuticos   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BARBIHYDAN; CLERIN; FENIDANTOIN S; FENIGRAMON; HYDANTOIN; PHENYTOIN; SACERIL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG IDENTIFICATION; DRUG QUALITY; QUALITY CONTROL; TABLET; TABLET DISINTEGRATION; WEIGHT;

EID: 0343488339     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709148481     Document Type: Article

References (10)

1. Martindale, The Extra Pharmacopoeia, 30th ed., James E. F. Reynolds, The Pharmaceutical Press, London, 1993.
2. Clarke's Isolation and Identification of Drugs, 2nd ed., A. C. Moffat, The Pharmaceutical Press, London, 1986.
3. Report of Ad Hoc Committee on Drug Product Selection of the Academy of General Practice of Pharmacy and the Academy of Pharmaceutical Sciences, J. Am. Pharm. Assoc. NS, 13, 278 (1973).
4. A. J. Glazko and T. Chang. Diphenylhydantoin: Absorption, distribution and excretion, in Antiepileptic Drugs (D. M. Woodbury, J. K. Penry, and R. P. Schmidt, eds.), Raven Press, New York, 1972, p. 127.
5. L. O. Boreus, A. Nergarth, M. Ehrnebo, and K. Theorell, J. Neurol., 223, 241 (1980).
6. P. J. Neuvonen, Clin. Pharmacokinet., 4, 91 (1979).
7. H. Blume, S. L. Ali, and M. Siewert, Drug Dev. Ind. Pharm., 19, 2713 (1993).
8. H. Blume, S. A. Qureshi, S. L. Ali, and I. J. McGilveray, Drug Dev. Ind. Pharm., 21, 925 (1995).
9. A. G. Davidson, Drug Dev. Ind. Pharm., 21, 2167 (1995).
10. S. Siegel, Estatística Não Paramética, McGraw-Hill, Rio Janeiro, 1975.